The effect of hepcidin on components of metabolic syndrome in chronic kidney disease: a cross-sectional study.

Sibel Gokcay Bek Berna Üstüner Necmi Eren Zeynep Sentürk Betül Kalender Gönüllü

Published in: Revista da Associacao Medica Brasileira (1992) (2020)

Hepcidin, a well-known hormone regulator of iron metabolism, may play an important role in the pathogenesis of metabolic syndrome in patients with CKD, and further studies might delineate in-depth its potential as a promising early marker in these patients.

Keyphrases

metabolic syndrome
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
insulin resistance
peritoneal dialysis
uric acid
prognostic factors
physical activity
type diabetes
patient reported